Mangalam Drugs & Organics

quarterly
yearly
ParticularsJun '23Sep '23Dec '23Mar '24Jun '24
Revenue87.4881.5997.34102.2976.55
Expenses97.7786.3397.2998.3475.97
EBITDA-3.452.226.9711.758.20
EBIT-6.88-1.513.357.894.33
Profit Before Tax-10.29-4.750.043.940.58
Net Profit-9.54-3.560.503.552.68
Financial Ratios
Operating Profit Margin-3.97%2.73%7.19%11.53%10.73%
Net Profit Margin-10.97%-4.38%0.52%3.48%3.50%
Earning Per Share (Diluted)-6.02-2.250.322.241.70
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.3.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ